Advertisement

Topics

Blood Test May Spot Lung Cancer's Return, Even Before Scans

08:03 EDT 20 Mar 2017 | Drugs.com

MONDAY, March 20, 2017 -- A blood test can detect the return of lung cancer months before CT and PET scans, a new study suggests. The research included 48 adults with stage 2 or 3 locally advanced non-small cell lung cancer (NSCLC). The patients...

Original Article: Blood Test May Spot Lung Cancer's Return, Even Before Scans

NEXT ARTICLE

More From BioPortfolio on "Blood Test May Spot Lung Cancer's Return, Even Before Scans"

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Gilotrif (afatinib)
GILOTRIF (afatinib) is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L8...